PRCT vs PRGO: Which Stock Is the Better Buy?
PROCEPT BioRobotics Corporation and Perrigo Company plc side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — PRCT vs PRGO, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| PROCEPT BioRobotics Corporation (PRCT) | Perrigo Company plc (PRGO) | |
|---|---|---|
| Market cap | $1.5B | $1.6B |
| Revenue (latest FY) | $308.05M | $4.25B |
| Net income (latest FY) | $-95.57M | $-1.43B |
| Revenue growth (5y CAGR) | 109.0% | 0.8% |
| Net margin | -31.0% | -33.5% |
| Return on equity | -26.1% | -48.6% |
| P/E ratio | — | — |
| Dividend yield | — | 10.4% |
| Profitable years (of last 10) | 0 | 3 |
| Positive free cash flow | No | Yes |
Verify the comparison
Use the filing period and source shown by each tool before treating two figures as comparable.
See the full PRCT vs PRGO breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open PRCT's full financials → Open PRGO's full financials →More comparisons
Frequently asked questions
Which is bigger, PRCT or PRGO?
Perrigo Company plc is larger by market capitalization — $1.6B versus $1.5B.
Which grows faster, PRCT or PRGO?
Over the last five fiscal years, PROCEPT BioRobotics Corporation grew revenue faster — 109.0%/yr versus 0.8%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.